What do Martin Shkreli, the co founder of 10 billion dollar pharma co., hedge funds and day traders have in common?
1
The turnaround is in its infancy, but has the ability to run
2
The device is great, but the trial results could disappoint.
Are you being Gaslit?, Thinking IS working, and reviewing Myomo, Performant, and Semler.
6
A long term stock limited by capacity, building a surgical platform with an exciting drug delivery business, new innovations on the horizon, too…
ZYXI was one of the biggest winners over the last five years nearly returning 100x: what did it look and feel like along the way?
1
Plus some thoughts on Specialists, Individual investors, PFMT, and NEPH
5
Boring isn't inactive, A New Add: $TRMR, Semler Update, 4 stocks on my watchlist: $BFIT, $NEPH, $LEE, $IDXG
1
See all

Medtech and Microcaps